Premier Biosoft and MRC-Holland Form Alliance
Premier Biosoft International and MRC-Holland have announced an alliance. Multiplex Ligation-dependent Probe Amplification (MLPA®) is a method to establish the copy number of up to 45 nucleic acid sequences in a single reaction.
Detecting copy number changes in the genome, the primary application of MLPA® technology, is a widely researched area.
MLPA® probes are able to discriminate between sequences that differ by just one nucleotide, making them a sensitive tool for detecting the changes.
The alliance will help MLPA® users design custom oligos for genes that do not have kits available. Currently, no such design tool exists.
"With this collaboration, both PREMIER Biosoft and MRC-Holland will use their core competencies and expertise to develop a powerful bioinformatics tool for MLPA® users," commented Kay Brown, V.P. Business Development and Marketing.